Event Description

Next-Generation Degraders & Glues 2022 London United Kingdom

The 2nd Annual conference on Next-Generation Degraders & Glues brings together experts in the field to discuss the new therapeutic modalities detailed below, as well as issues underlying the use of targeted degradation as a new therapeutic approach.

The ubiquitin-proteasome, lysosome, and autophagy systems are all well-controlled, selective degradation pathways that are key cellular regulators in cancer, CNS, and other diseases. A new generation of hetero bi-functional chimeras and small molecule monovalent degraders are being developed to hijack these systems for targeted protein degradation or stabilization. These molecules that include Proteolysis-targeting chimeras (PROTACs) and molecular glues are being used to seek out previously “undruggable” targets for therapeutic intervention. However, challenges do exist in terms of specificity, stability, biodistribution, and penetration of these degrader molecules.

Submit a speaker proposal, register, or become a sponsor!

End Date
Start Date
For registration/tickets purchase:
Currency Symbol:
Event Cost:
Designing and Optimizing PROTACs, Molecular Glues, and Other Degrader Modalities
Event Types (Select all that apply)
Medical Convention
Medical Conference
Medical Seminar
Event Registration Contact Email
Event Information Contact Email
CME Credits
Abstract Submission Deadline
(+1) 206-575-7771
Medical Events Worldwide
12922 SE 299th Street, Auburn WA 98092 USA